Volume 128, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
Volume 115, Issue 4, Pages (October 1998)
Advertisements

Volume 141, Issue 2, Pages e2 (August 2011)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 136, Issue 1, Pages (January 2009)
Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Volume 33, Issue 2, Pages (August 2010)
Volume 25, Issue 2, Pages (August 2006)
Volume 137, Issue 3, Pages (September 2009)
Volume 133, Issue 5, Pages (November 2007)
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 5, Pages (November 2012)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 136, Issue 1, Pages (January 2009)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 143, Issue 6, Pages e7 (December 2012)
The tyrosine phosphatase SHP-1 dampens murine Th17 development
Volume 136, Issue 3, Pages (March 2009)
Volume 129, Issue 1, Pages (July 2005)
Volume 130, Issue 2, Pages (February 2006)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 134, Issue 2, Pages (February 2008)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 122, Issue 1, Pages (January 2002)
Volume 42, Issue 5, Pages (May 2015)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 141, Issue 5, Pages (November 2011)
Volume 119, Issue 4, Pages (October 2000)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 3, Pages (March 2007)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 126, Issue 7, Pages (June 2004)
Volume 30, Issue 3, Pages (March 2009)
Volume 132, Issue 7, Pages (June 2007)
Volume 137, Issue 3, Pages (September 2009)
Volume 135, Issue 3, Pages e5 (September 2008)
Volume 18, Issue 5, Pages (May 2003)
Volume 140, Issue 7, Pages (June 2011)
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Volume 137, Issue 5, Pages (November 2009)
Volume 28, Issue 4, Pages (April 2008)
Volume 143, Issue 1, Pages (July 2012)
Volume 33, Issue 2, Pages (August 2010)
Volume 138, Issue 2, Pages (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 128, Issue 3, Pages (March 2005)
Volume 120, Issue 4, Pages (March 2001)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 135, Issue 5, Pages e5 (November 2008)
Volume 134, Issue 4, Pages (April 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 150, Issue 7, Pages (June 2016)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 142, Issue 5, Pages (May 2012)
Volume 16, Issue 2, Pages (February 2002)
Volume 119, Issue 3, Pages (September 2000)
Volume 41, Issue 4, Pages (October 2014)
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
Volume 17, Issue 2, Pages (February 2009)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 126, Issue 6, Pages (September 2006)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 131, Issue 2, Pages (August 2006)
Volume 34, Issue 3, Pages (March 2011)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 131, Issue 6, Pages (December 2006)
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 128, Issue 5, Pages 1268-1277 (May 2005) In Vivo Generation of Oligoclonal Colitic CD4+ T-Cell Lines Expressing a Distinct T-Cell Receptor Vβ  Ana C. Abadía-Molina, Atsushi Mizoguchi, William A. Faubion, Ype P. de Jong, Svend T. Rietdijk, Martina Comiskey, Kareem Clarke, Atul K. Bhan, Cox Terhorst  Gastroenterology  Volume 128, Issue 5, Pages 1268-1277 (May 2005) DOI: 10.1053/j.gastro.2005.01.060 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Sequential adoptive transfers (ATs) of colitis-inducing CD4+ T cells isolated from mesenteric lymph nodes (MLN) of AT experiment A (lines 1 and 2). (A) Schematic outline of the results of sequential ATs into tgϵ26, C3H/HeN × Rag−/−, or BALB/c × Rag−/− mice. After colitis developed in BM→tgϵ26 mice, CD4+ cells purified from the MLNs were transferred into healthy tgϵ26 mice (AT 1). Transfer of MLN CD4+ cells into tgϵ26 mice was repeated in AT 2, AT 3, and AT 4. Parallel transfers of MLN CD4+ cells into C3H/HeN × Rag−/− or BALB/c × Rag−/− mice were also performed in AT 1 and AT 4. (B) Disease activity index (DAI) and histology scores of the 3 BM→tgϵ26 mice with colitis. (C) DAI and histology scores of tgϵ26, C3H/HeN × Rag−/−, and BALB/c × Rag−/− mice after AT 1 (mouse AT 1 no. 198, 2253, and 2256). (D) DAI and histology scores of tgϵ26, C3H/HeN × Rag−/−, and BALB/c × Rag−/− mice with colitis after AT 4. ATs of the CD4+ cells from mice at AT 3 in lines 1 and 2 induced colitis in tgϵ26 and C3H/HeN × Rag−/− mice, in contrast to BALB/c × Rag−/− mice, as in AT 1. Statistical significance was calculated by comparing the DAI or histology scores of BALB/c × Rag−/− mice with those of tgϵ26 mice (DAI, P = .008; histology, P = .008) or those of C3H × Rag−/− mice (DAI, P = .05; histology score, P = .05) from AT experiment A. (E) Flow cytometric analyses of line 1 LPL cells showing an enrichment of Vβ8S1/2 CD4+ cells after AT 4. Lamina propria CD4+ T cells were analyzed for expression of 15 Vβ family members by flow cytometry, as described in Materials and Methods. Shown here is the enrichment of the major Vβ8S1/2 population from MLN→tgϵ26 mice of cell line 1. Cells were gated for lymphocyte side scatter vs CD4+ expression. (F) Representative histology of inflamed colon tissue. Histology of colon tissue of a healthy WT (CBA × C57BL/6) mouse, of a diseased BM→tgϵ26 mouse (DAI score, 6), a tgϵ26 mouse (AT 1 no. 198; DAI score, 5), and a tgϵ26 mouse (AT 4 no. 2219; DAI score, 3.5) is shown (original magnification, 10×). (G) Cytokine production by lamina propria CD4+ cells of experiment A. IL-4, IL-10, and IFN-γ cytokines were measured by enzyme-linked immunosorbent assay in the supernatant of colon LPL from BM→tgϵ26 (n = 3) mice with plate-bound anti-CD3 (145.2C11) and APCs pulsed with cecal antigens for 36 hours. Ag, antigen. Gastroenterology 2005 128, 1268-1277DOI: (10.1053/j.gastro.2005.01.060) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Cytokine production of MLNs and memory/effector phenotype of MLN and LPL cells from experiment A. (A) Cytokine production by MLN cells. IL-4, IL-10, and IFN-γ cytokines were measured by enzyme-linked immunosorbent assay in the supernatant of MLNs from BM→tgϵ26 (n = 3) and AT 4 (n = 2) cultured with plate bound anti-CD3, and APCs were pulsed with cecal antigen for 36 hours. (B) Flow cytometric analyses of MLNs and LPLs showing a memory/effector phenotype of CD4 cells. Flow cytometry diagrams were generated with anti-CD4+ and anti-Vβ8S1/2, -CD62-L, -CD45RB, and -CD69 of colonic lamina propria and MLN CD4+ cells isolated from colitic tgϵ26 mice, as described in Materials and Methods. Representative data are shown of 1 (AT 4 no. 2219; line 1) of 30 mice analyzed in 2 sequential adoptive transfer experiments. The percentage of CD69 ranged from 43% to 90% in LPLs and from 12% to 60% in MLNs. The percentage of CD62L ranged from 1% to 11% in LPLs and from 1% to 16% in MLNs. The percentage of CD45RBhi ranged from 0% to 2% in LPLs and from 0% to 2.5% in MLNs. Ag, antigen. Gastroenterology 2005 128, 1268-1277DOI: (10.1053/j.gastro.2005.01.060) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Schematic outline of sequential adoptive transfers of colitis inducing CD4+ T-cell lines. Upon transfer of WT bone marrow into 15 tgϵ26 recipients, colitis developed after 4 weeks; MLN CD4+ cells were isolated and transferred sequentially as outlined (line 3). CD4+ cells from the spleens of the same 15 colitic animals were used for lines 4 to 7. Sequential transfers of CD4+ cells from MLNs were performed into individual tgϵ26 mice as indicated (numbers). CD4+ MLN cells were also transferred into tgϵ26, C3H/HeN × SCID, or BALB/c × SCID mice in cell line 3 and cell line 4 or into C3H/HeN × Rag−/− and BALB/c × Rag−/− mice in cell line 5. Disease was scored for each mouse as indicated in Materials and Methods. BIDMC, animal research facility, Beth Israel Deaconess Medical center; J, Jackson Laboratories; T, Taconic Laboratories. Gastroenterology 2005 128, 1268-1277DOI: (10.1053/j.gastro.2005.01.060) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 DAI and histology scores of tgϵ26, C3H/HeN × Rag−/−, or SCID and BALB/c × Rag−/− or SCID mice in lines 3, 4, and 5. CD4+ MLN cells from mice at AT 5 in lines 3 and 4 and at AT 6 and AT 7 in line 5 were transferred into tgϵ26 (n = 5 and n = 3, respectively) and C3H/HeN × Rag−/− (n = 3) or C3H/HeN × SCID (n = 3) as outlined in Figure 3. C3H/HeN × Rag−/− or SCID mice develop colitis, as do their tgϵ26 counterparts. *P < .05, calculated comparing DAI or histology scores of BALB/c × Rag−/− or BALB/c × SCID mice with those of tgϵ26, C3H × Rag−/−, or C3H × SCID mice. Median and independent values for DAI and histology scores are shown. Gastroenterology 2005 128, 1268-1277DOI: (10.1053/j.gastro.2005.01.060) Copyright © 2005 American Gastroenterological Association Terms and Conditions